文献速递前列腺增生与排尿功能障碍前列腺癌

偶发性前列腺淀粉样变性的临床意义

The Clinical Implication of Incidental Prostatic Amyloidosis.
PubMed 文献 · Urology · 2020-09-19

该研究回顾了Mayo Clinic Arizona 2008至2018年间7例偶发前列腺淀粉样变性患者,中位年龄79岁,中位随访5年。6例分型均为转甲状腺素蛋白淀粉样变性(ATTR),其中5例合并心脏淀粉样变性。结论认为偶发前列腺淀粉样变性应启动全身及心脏评估,疑似心脏淀粉样变性时应回顾前列腺标本。

要点

  • 偶发前列腺淀粉样变性应启动全身及心脏淀粉样变性评估。
  • 前列腺淀粉样变性多为ATTR型,常与心脏淀粉样变性相关。
  • 疑似心脏淀粉样变性时,应回顾既往前列腺标本是否存在淀粉样沉积。

核心结论

  • 偶发性前列腺淀粉样变性应促使对患者进行全身及心脏淀粉样变性评估。
  • 对疑似心脏淀粉样变性的患者,应回顾既往前列腺标本以寻找淀粉样变性证据。

研究设计与样本

  • 回顾性查询Mayo Clinic Arizona泌尿生殖病理数据库,纳入2008至2018年前列腺标本显示淀粉样沉积的7例患者。
  • 采用刚果红染色诊断淀粉样变性,并用液相色谱串联质谱进行淀粉样亚型分析。
  • 回顾病历了解既往或后续系统性淀粉样变性诊断及临床病程。

主要发现

  • 共识别7例前列腺淀粉样变性患者,中位年龄79岁(范围69-84),中位随访5年(范围0-11)。
  • 4例为良性前列腺组织,3例诊断为前列腺癌。
  • 6例可进行淀粉样亚型分析,均符合转甲状腺素蛋白淀粉样变性(ATTR)。
  • 液相色谱串联质谱未在任何患者中检测到转甲状腺素蛋白氨基酸序列异常。
  • 6例中5例诊断为心脏淀粉样变性,其中1例诊断在前列腺淀粉样变性之前,4例在其后。

关键数值与推荐

  • 7例患者中6例淀粉样亚型分析符合ATTR型。
  • 6例中5例合并心脏淀粉样变性;4例心脏诊断在前列腺诊断之后,其中2例因前列腺淀粉样变性诊断而立即诊断,另2例分别在3年和4年后诊断。

临床怎么用

  • 对偶发前列腺淀粉样变性患者,应进行全身及心脏淀粉样变性评估。
  • 对疑似心脏淀粉样变性患者,应回顾既往前列腺标本是否存在淀粉样沉积。

局限性

  • 样本量小(7例),为单中心回顾性研究。
  • 淀粉样亚型分析仅6例可用,随访时间范围宽(0-11年)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the clinicopathologic features of patients with incidental prostatic amyloidosis. PATIENTS AND METHODS: We queried the genitourinary pathology database at Mayo Clinic Arizona for prostate specimens which showed amyloid deposits. Congo red stain was used for the diagnosis of amyloidosis and amyloid subtype was performed analysis using Liquid chromatography tandem mass spectrometry. We reviewed the patient's medical charts for past or subsequent diagnosis of systemic amyloidosis and clinical course. RESULTS: Prostatic amyloidosis was identified in 7 patients between 2008-2018. Median age was 79 years (range 69-84) and median follow-up was 5 years (range 0-11). Benign prostate tissue was found in 4 patients, and prostate cancer was diagnosed in 3 patients. Amyloid subtyping was available in 6 patients and was consistent with Amyloid transthyretin Amyloidosis. Liquid chromatography tandem mass spectrometry did not detect an amino acid sequence abnormality in the transthyretin protein in any of the patients. Five of 6 patients were diagnosed with cardiac amyloidosis, which preceded and followed the diagnosis of prostatic amyloidosis in 1 and 4 patients, respectively. Of these 4 patients, 2 were diagnosed immediately and as a consequence of the diagnosis of prostatic amyloidosis, and the remaining 2 3 and 4 years later. CONCLUSION: Incidental prostatic amyloidosis should prompt systemic and cardiac evaluation for amyloidosis. In patients with suspected cardiac amyloidosis, prior prostate specimens should be reviewed for the presence of amyloidosis.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Nevo A, Muchtar E, Stern KL, et al. The Clinical Implication of Incidental Prostatic Amyloidosis. Urology. 2020. PMID: 32961226. doi:10.1016/j.urology.2020.08.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。